Targeting inflammasome complexes as a novel therapeutic strategy for mood disorders

Aline Silva de Miranda, Eliana Cristina de Brito Toscano, Jason C. O’Connor, Antonio Lucio Teixeira

Research output: Contribution to journalReview articlepeer-review

Abstract

Introduction: Inflammasome complexes, especially NLRP3, have gained great attention as a potential therapeutic target in mood disorders. NLRP3 triggers a caspase 1-dependent release of the inflammatory cytokines IL-1β and IL-18, and seems to interact with purinergic and kynurenine pathways, all of which are implicated in mood disorders development and progression. Areas covered: Emerging evidence supports NLRP3 inflammasome as a promising pharmacological target for mood disorders. We discussed the available evidence from animal models and human studies and provided a reflection on drawbacks and perspectives for this novel target. Expert opinion: Several studies have supported the involvement of NLRP3 inflammasome in MDD. However, most of the evidence comes from animal models. The role of NLRP3 inflammasome in BD as well as its anti-manic properties is not very clear and requires further exploration. There is evidence of anti-manic effects of P2×R7 antagonists associated with reduction in the brain levels of IL-1β and TNF-α in a murine model of mania. The involvement of other NLRP3 inflammasome expressing cells besides microglia, like astrocytes, and of other inflammasome complexes in mood disorders also deserves further investigation. Preclinical and clinical characterization of NLRP3 and other inflammasomes in mood disorders is needed before considering translational approaches, including clinical trials.

Original languageEnglish (US)
Pages (from-to)401-418
Number of pages18
JournalExpert opinion on therapeutic targets
Volume28
Issue number5
DOIs
StatePublished - 2024
Externally publishedYes

Keywords

  • Mood disorders
  • NLRP3
  • P2XR7
  • bipolar disorder
  • cytokines
  • depression
  • inflammasome

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Fingerprint

Dive into the research topics of 'Targeting inflammasome complexes as a novel therapeutic strategy for mood disorders'. Together they form a unique fingerprint.

Cite this